Zydus

A collection of 3 posts

Torrent, Zydus Partner to Co-Market Saroglitazar for Chronic Liver Diseases in India

Torrent, Zydus Partner to Co-Market Saroglitazar for Chronic Liver Diseases in India

Torrent Pharmaceuticals and Zydus Lifesciences join forces to co-market Saroglitazar Mg, the exclusive treatment for NASH and NAFLD in India. With unique properties benefiting millions since 2013

Zydus and Lupin Join Forces to Market Liver Disease Drug

Zydus and Lupin Join Forces to Market Liver Disease Drug

Zydus Lifesciences and Lupin have forged a strategic partnership to market Saroglitazar Mg, a breakthrough drug for Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steato Hepatitis (NASH) in India. Lupin will have semi-exclusive rights to co-market the drug as LINVAS.

Zydus Lifesciences Acquires UK-Based LiqMeds Group for INR 690 Crores

Zydus Lifesciences Acquires UK-Based LiqMeds Group for INR 690 Crores

Zydus Lifesciences has made a significant move by acquiring the UK-based LiqMeds Group in a GBP 68 million all-cash deal. This acquisition is set to strengthen Zydus' position in the pharmaceutical industry and expand its product portfolio.